In other autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, or type 1 diabetes, it has been shown that post-translational modifications of autoantigens can elicit the formation of CD4+ T cell responses as well as create neo-epitopes that are recognized by B cells. This evidence concerns the gene CD4 and type 1 diabetes mellitus.